Remove en data-collection
article thumbnail

Industry group says FDA botched COVID-19 convalescent plasma guidance

pharmaphorum

The problem lies with the requirement that each unit of plasma includes information on the concentration of antibody titres, something which wasn’t required for CCP units collected ahead of the EUA on 23 August. As it stands, only one or two people out of 100 would be expected to die if they had COVID-19, so the claim makes little sense.

Antibody 105
article thumbnail

FOLLOW-UP DATA FROM PHASE 3 TRIAL OF PFIZER-BIONTECH COVID-19 VACCINE SUPPORT SAFETY AND HIGH EFFICACY IN ADOLESCENTS 12 THROUGH 15 YEARS OF AGE

The Pharma Data

Data will support planned cessions for full nonsupervisory blessing of the vaccine in this age group in theU.S. View the full release then https//www.businesswire.com/news/home/20211122005249/en/. We look forward to participating these data with the FDA and other controllers.”. This press release features multimedia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer

The Pharma Data

De laatste handelsdag van de Aandelen aan Euronext Amsterdam en Euronext Brussel (“ Euronext “) zal op 24 mei 2021 zijn en de notering van en de handel in de Aandelen zal eindigen per 25 mei 2021. Overdracht van de Aandelen en betaling van de Biedprijs zal plaatsvinden op 3 mei 2021. ING Bank N.V.

article thumbnail

Delisting of Kiadis will be effective on 25 May 2021

The Pharma Data

De laatste datum waarop de Aandelen kunnen worden verhandeld aan Euronext Amsterdam en Euronext Brussel (‘’ Euronext ’’) zal op 24 mei 2021 zijn, en de notering van en de handel in de Aandelen zal eindigen op 25 mei 2021. a) ( Intentions following the Offer being declared unconditional ) en Hoofdstuk 6.11(b)

article thumbnail

Digital health firm Lyra enters unicorn territory after fundraising

pharmaphorum

I believe we will look back on 2020 as a turning point in our collective recognition that the mental health status quo is not good enough,” says Ebersman, in a reference to data the company generated with the National Alliance of Healthcare Purchaser Coalitions in July which suggested that 83% of US employees are experiencing mental health issues.

article thumbnail

Decentralised identities: Blockchain based informed consent

Drug Discovery World

There are several challenges associated with centralised data and ID management such as databases being at risk of single point of failure leading to data loss and higher risk of targeted data breaches leading to compromised data security. for sponsors or sites, or private, eg. for clinical trial participants.

article thumbnail

Decentralised identities: Blockchain based informed consent

Drug Discovery World

There are several challenges associated with centralised data and ID management such as databases being at risk of single point of failure leading to data loss and higher risk of targeted data breaches leading to compromised data security. for sponsors or sites, or private, eg. for clinical trial participants.